Fri. 09/28
Session F.10 / OS Organhall / 10.30 - 12.30 am
Clinical Dialysis 2
Chairman 1: Ivanovich, / Chairman 2: J. Fort Ros, Barcelona Spain
| 10.30 - 10.45 am | O100 | Hemofiltration with endogenous reinfusion (HFR): viable therapy to enhance middle and large molecular size solute removal J. Fort Ros, Barcelona, Spain |
| 10.45 - 11.00 am | O101 | Does the daily sodium intake influence mortality in dialysis patients? G. Severova- Andreevska, Skopje, Macedonia |
| 11.00 - 11.15 am | O102 | Retracted |
| 11.15 - 11.30 am | O103 | Impact on heparin dosage and compatibility using a citrate enriched dialysate in high-flux dialysis W. Paetow, Rostock, Germany |
| 11.30 - 11.45 am | O104 |
Microembolies of air are deposited in the lungs of haemodialysis patients |
| 11.45 - 12.00 am | O105 | Acetate free Hemodialysis A. Amore, Torino, Italy |
| 12.00 - 12.15 am | O106 | HOW IMPORTANT IS THE DIALSATE FLOW DURING HEMODIALYSIS TREATMENTS P. Ahrenholz, Rostock, Germany |
| 12.15 - 12.30 am | O107 | Clotting factors in patients with end stage renal disease P. Dejanov, Skopje, Macedonia |